Cabot Wealth Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-967
| Closed | -$238K | – | 158 |
|
|
2022
Q3 | $238K | Hold |
967
| – | – | 0.04% | 140 |
|
|
2022
Q2 | $239K | Hold |
967
| – | – | 0.04% | 139 |
|
|
2022
Q1 | $320K | Sell |
967
-200
| -17% | -$61.6K | 0.04% | 136 |
|
|
2021
Q4 | $419K | Hold |
1,167
| – | – | 0.05% | 129 |
|
|
2021
Q3 | $380K | Sell |
1,167
-100
| -8% | -$33.9K | 0.05% | 125 |
|
|
2021
Q2 | $395K | Hold |
1,267
| – | – | 0.05% | 123 |
|
|
2021
Q1 | $404K | Hold |
1,267
| – | – | 0.06% | 119 |
|
|
2020
Q4 | $411K | Sell |
1,267
-87
| -6% | -$24.1K | 0.06% | 110 |
|
|
2020
Q3 | $375K | Sell |
1,354
-160
| -11% | -$46.1K | 0.07% | 105 |
|
|
2020
Q2 | $365K | Sell |
1,514
-25
| -2% | -$5.02K | 0.07% | 104 |
|
|
2020
Q1 | $223K | Hold |
1,539
| – | – | 0.05% | 110 |
|
|
2019
Q4 | $263K | Sell |
1,539
-50
| -3% | -$9.27K | 0.05% | 113 |
|
|
2019
Q3 | $283K | Hold |
1,589
| – | – | 0.06% | 114 |
|
|
2019
Q2 | $414K | Sell |
1,589
-87
| -5% | -$23.1K | 0.09% | 97 |
|
|
2019
Q1 | $479K | Hold |
1,676
| – | – | 0.11% | 93 |
|
|
2018
Q4 | $545K | Sell |
1,676
-2,479
| -60% | -$861K | 0.13% | 92 |
|
|
2018
Q3 | $1.87M | Buy |
4,155
+1,929
| +87% | +$760K | 0.4% | 67 |
|
|
2018
Q2 | $911K | Hold |
2,226
| – | – | 0.2% | 81 |
|
|
2018
Q1 | $648K | Hold |
2,226
| – | – | 0.14% | 85 |
|
|
2017
Q4 | $417K | Hold |
2,226
| – | – | 0.09% | 100 |
|
|
2017
Q3 | $375K | Hold |
2,226
| – | – | 0.08% | 101 |
|
|
2017
Q2 | $319K | Hold |
2,226
| – | – | 0.07% | 112 |
|
|
2017
Q1 | $279K | Hold |
2,226
| – | – | 0.07% | 119 |
|
|
2016
Q4 | $251K | Hold |
2,226
| – | – | 0.07% | 131 |
|
|
2016
Q3 | $286K | Hold |
2,226
| – | – | 0.07% | 126 |
|
|
2016
Q2 | $243K | Hold |
2,226
| – | – | 0.06% | 132 |
|
|
2016
Q1 | $211K | Sell |
2,226
-100
| -4% | -$8.44K | 0.06% | 133 |
|
|
2015
Q4 | $210K | Hold |
2,326
| – | – | 0.05% | 138 |
|
|
2015
Q3 | $216K | Buy |
+2,326
| New | +$205K | 0.06% | 131 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Cabot Wealth Management's ABMD Position: Q4 2022 in Review
Cabot Wealth Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 967 shares — an estimated $238K sold.
Cabot Wealth Management first reported a position in ABMD in Q3 2015 and held it in 29 quarters. The position peaked at $1.87M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Cabot Wealth Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Cabot Wealth Management sold 967 Abiomed Inc shares in Q4 2022, an estimated $238K.
- Cabot Wealth Management first reported a position in Abiomed Inc in Q3 2015 and held it in 29 quarters.
- Cabot Wealth Management's Abiomed Inc position peaked at $1.87M in Q3 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Cabot Wealth Management's 13F filing for Q4 2022, filed 31 Jan 2023.